Same Indication

Ipilimumab vs Memantine

Ipilimumab vs Memantine: Overview

This comparison examines the pharmacological differences between Ipilimumab and Memantine.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Memantine: Non-competitive NMDA receptor antagonist.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Memantine — 60-80 hours.

Chemical Properties

Molecular Formula: Memantine — C12H21N.

Molecular Weight: Memantine — 179.3080 g/mol.

Type: Ipilimumab — Antibody; Memantine — Small molecule.